Partial List of Clinical Studies and articles: (Click on the name of the study to read more)

1. Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.
Ulbricht C, Basch E, Szapary P, Hammerness P, Axentsev S, Boon H, Kroll D, Garraway L, Vora M, Woods J; Natural Standard Research Collaboration.
Complement Ther Med. 2005 Dec;13(4):279-90. Epub 2005 Sep 23.

2. Herbs for serum cholesterol reduction: a systematic view.
Thompson Coon JS, Ernst E.
J Fam Pract. 2003 Jun;52(6):468-78.

3. GUGULIPID: a natural cholesterol-lowering agent.
Urizar NL, Moore DD.
Annu Rev Nutr. 2003;23:303-13. Epub 2003 Feb 26.

4. A natural product that lowers cholesterol as an antagonist ligand for FXR.
Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y, Gonzalez FJ, Heyman RA, Mangelsdorf DJ, Moore DD.
Science. 2002 May 31;296(5573):1703-6. Epub 2002 May 2

5. Bioactive terpenoids and guggulusteroids from Commiphora mukul gum resin of potential anti-inflammatory interest.
Francis JA, Raja SN, Nair MG.
Chem Biodivers. 2004 Nov;1(11):1842-53.

6. Is antagonism of E/Z-guggulsterone at the farnesoid X receptor mediated by a noncanonical binding site? A molecular modeling study.
Meyer U, Costantino G, Macchiarulo A, Pellicciari R.
J Med Chem. 2005 Nov 3;48(22):6948-55.

7. Guggulu (Commiphora mukul) potentially ameliorates hypothyroidism in female mice.
Panda S, Kar A.
Phytother Res. 2005 Jan;19(1):78-80.

8. Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis.
Shishodia S, Aggarwal BB.
J Biol Chem. 2004 Nov 5;279(45):47148-58. Epub 2004 Aug 17.

9. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL.
Wang X, Greilberger J, Ledinski G, Kager G, Paigen B, Jurgens G.
Atherosclerosis. 2004 Feb;172(2):239-46.